Beam Therapeutics Inc. (BEAM)
Company Info
| ISIN | US07373V1052 |
|---|---|
| CUSIP | 07373V105 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $2.70B |
|---|---|
| EPS | -$1.72 |
| Revenue (TTM) | $377.71M |
| Gross Profit (TTM) | -$250.67M |
| EBITDA (TTM) | -$156.47M |
| Year Range | $16.95 - $49.50 |
| Target Price | $50.08 |
| Short % | 22.23% |
| Short Ratio | 8.36 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BEAM vs. CRSP, BEAM vs. TWST, BEAM vs. SCHD, BEAM vs. SPY
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Beam Therapeutics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Beam Therapeutics Inc. had a return of -5.58% year-to-date (YTD) and -19.31% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -5.58% | 5.90% |
| 1 month | -27.42% | -1.28% |
| 6 months | 15.40% | 15.51% |
| 1 year | -19.31% | 21.68% |
| 5 years (annualized) | N/A | 11.74% |
| 10 years (annualized) | N/A | 10.50% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -10.36% | 61.84% | -16.33% | |||||||||
| 2023 | 3.75% | -12.10% | 32.83% | -3.06% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Beam Therapeutics Inc.(BEAM)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Beam Therapeutics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Beam Therapeutics Inc. was 86.76%, occurring on Oct 20, 2023. The portfolio has not yet recovered.
The current Beam Therapeutics Inc. drawdown is 80.76%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -86.76% | Jul 2, 2021 | 580 | Oct 20, 2023 | — | — | — |
| -54.42% | Feb 14, 2020 | 21 | Mar 16, 2020 | 77 | Jul 6, 2020 | 98 |
| -46.9% | Feb 9, 2021 | 63 | May 10, 2021 | 36 | Jun 30, 2021 | 99 |
| -37.83% | Jul 10, 2020 | 17 | Aug 3, 2020 | 52 | Oct 15, 2020 | 69 |
| -20.59% | Jan 19, 2021 | 6 | Jan 26, 2021 | 8 | Feb 5, 2021 | 14 |
Volatility
Volatility Chart
The current Beam Therapeutics Inc. volatility is 13.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |